NEWLY DIAGNOSED H3-MUTATED GLIOMA

Clinical trials for NEWLY DIAGNOSED H3-MUTATED GLIOMA explained in plain language.

Never miss a new study

Get alerted when new NEWLY DIAGNOSED H3-MUTATED GLIOMA trials appear

Sign up with your email to follow new studies for NEWLY DIAGNOSED H3-MUTATED GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First-in-Human trial tests 'Vaccine' to train immune system against deadly brain cancer

Disease control Ongoing

This early-stage trial is testing a new personalized vaccine designed to treat a specific, hard-to-treat brain tumor called H3-mutated glioma. The vaccine aims to teach the patient's own immune system to recognize and attack the cancer cells. It is being given alongside standard …

Matched conditions: NEWLY DIAGNOSED H3-MUTATED GLIOMA

Phase: PHASE1 • Sponsor: German Cancer Research Center • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

NEWLY DIAGNOSED H3-MUTATED GLIOMA

Get alerted when new NEWLY DIAGNOSED H3-MUTATED GLIOMA trials appear

First-in-Human trial tests 'Vaccine' to train immune system against deadly brain cancer